AMENDMENT NO. 1 TO FINISHED PRODUCT SUPPLY AGREEMENTFinished Product Supply Agreement • April 19th, 2005 • Inyx Inc • Pharmaceutical preparations
THIS AMENDMENT NO. 1 (the “Amendment No. 1”) dated as of April 15, 2005 with an effective date of April 1, 2005 (the “Amendment No. 1 Effective Date”) to the Finished Product Supply Agreement (the “Supply Agreement”) dated as of March 5, 2004 and effective as of March 31, 2004, is made and entered into by and between Inyx, Inc. (“Inyx”), the assignee and successor in interest to Aventis Pharmaceuticals Inc. and its Affiliates (“Aventis”) and Aeropharm Technology, LLC, the successor in interest to Aeropharm Technology, Inc. (“Purchaser”). Capitalized terms used in this Amendment No. 1 shall have the meanings ascribed to them in of the Supply Agreement, unless as otherwise provided herein.
FINISHED PRODUCT SUPPLY AGREEMENTFinished Product Supply Agreement • December 26th, 2013 • Aptalis Holdings Inc. • Pharmaceutical preparations • New York
THIS FINISHED PRODUCT SUPPLY AGREEMENT (this “Agreement”) dated as of October 8, 2003, and effective as of the Closing Date (the “Effective Date”) is made and entered into by and between Aventis Pharmaceuticals Inc., a company organized and existing under the laws of Delaware (“Aventis”), and Axcan Pharma Inc., a corporation organized and existing under the laws of Canada (“Axcan Pharma”, on behalf of itself and its Affiliates, collectively, the “Purchaser”). Capitalized terms used in this Agreement shall have the meanings ascribed to them in Article 1 hereof or as otherwise set forth herein; capitalized terms used herein without definition shall have the meanings ascribed to them in the Product Acquisition Agreement (as defined below).
FINISHED PRODUCT SUPPLY AGREEMENTFinished Product Supply Agreement • July 18th, 2005 • Warner Chilcott CORP • New York
** ] = PORTIONS OF THIS AGREEMENT HAVE BEEN OMITTED FROM THIS EXHIBIT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. AN UNREDACTED VERSION OF THIS AGREEMENT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. FINISHED PRODUCT...Finished Product Supply Agreement • October 7th, 2008 • Axcan Intermediate Holdings Inc. • Wholesale-drugs, proprietaries & druggists' sundries • New York
THIS FINISHED PRODUCT SUPPLY AGREEMENT (this “Agreement”) dated as of October 8, 2003, and effective as of the Closing Date (the “Effective Date”) is made and entered into by and between Aventis Pharmaceuticals Inc., a company organized and existing under the laws of Delaware (“Aventis”), and Axcan Pharma Inc., a corporation organized and existing under the laws of Canada (“Axcan Pharma”, on behalf of itself and its Affiliates, collectively, the “Purchaser”). Capitalized terms used in this Agreement shall have the meanings ascribed to them in Article 1 hereof or as otherwise set forth herein; capitalized terms used herein without definition shall have the meanings ascribed to them in the Product Acquisition Agreement (as defined below).
